Bosnian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
pancreatic neoplasms/dijareja
Veza se sprema u međuspremnik
Page 1 od 438 rezultati
Neuroendocrine Pancreatic Tumor Causing Chronic Diarrhea in Young Adult, a Case Report
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Secretory tumors of vasoactive intestinal polypeptides (VIPomas) are rare neuroendocrine pancreatic neoplasms usually associated with secretory diarrhea. Most cases present themselves with diarrhea, weight loss, and hypokalemia. Although VIPoma patients share easily distinguishable symptoms, early
Persistent Diarrhea after Celiac Plexus Block in a Pancreatic Cancer Patient: Case Report and Literature Review.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND
Neurolytic celiac plexus block is increasingly used to treat refractory pain associated with abdominal malignancies, especially pancreatic cancer. While self-limiting diarrhea can occur commonly in patients post procedure, a very rare risk of persistent diarrhea exists.
OBJECTIVE
We
[Current diagnostic and therapeutic possibilities in pancreatic tumors with secretory diarrhea].
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
[Chronic diarrhea and weight loss: pancreatic cancer - but which one?].
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Pancreatic Tumor Presenting as Diarrhea.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Clinical conference. Hormonal diarrhea due to pancreatic tumor.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Pancreatic tumor associated with flushing and diarrhea. Report of a case.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Pancreatic tumor with intractable watery diarrhea, hypokalemia and hypercalcemia electrolyte balance studies.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Small intestine bacterial overgrowth: an underdiagnosed cause of diarrhea in patients with pancreatic cancer.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
[Structural and ultrastructural findings concerning pancreatic neoplasms associated with the WDHA syndrome (watery diarrhea-hypokalemia-achlorhydria syndrome)].
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
[Exocrine pancreatic insufficiency, pancreatic cancer and mesenteric artery stenosis: A rare combination of different diseases leading to an increasing frequency of diarrhea].
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
The actions of the vasoactive intestinal polypeptide make it a potential candidate for mediating certain manifestations of the watery-diarrhea syndrome. Peptide levels were measured by radioimmunoassay in 25 controls and 30 patients with chronic watery diarrhea. Plasma levels were too low to measure
Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
OBJECTIVE
This multicenter, open-label, phase II study was undertaken to assess the antitumor activity and safety of the oral mitogen-activated extracellular signal regulated kinase kinase (MEK) inhibitor, CI-1040, in breast cancer, colon cancer, non-small-cell lung cancer (NSCLC), and pancreatic
[FOLFIRINOX Combination Chemotherapy in Patients with Metastatic or Recurrent Pancreatic Cancer--A Single Institution Experience].
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Pancreatic adenocarcinoma is one of the leading causes of cancer-related deaths in Japan. oxaliplatin: L-OHP, irinotecan: CPT-11, fluorouracil: 5-FU, and Leucovorin: l-LV (FOLFIRINOX) combination chemotherapy provided significant improvements in overall and progression-free survival in a phase Ⅲ
A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
OBJECTIVE
Preclinical and clinical studies have demonstrated that inhibition of prenylation can radiosensitize cell lines with activation of Ras and produce clinical response in patients with cancer. The aim of this study was to determine the maximally tolerated dose of the dual farnesyltransferase
Najkompletnija baza ljekovitog bilja potpomognuta naukom
- Radi na 55 jezika
- Biljni lijekovi potpomognuti naukom
- Prepoznavanje biljaka po slici
- Interaktivna GPS karta - označite bilje na lokaciji (uskoro)
- Pročitajte naučne publikacije povezane sa vašom pretragom
- Pretražite ljekovito bilje po učincima
- Organizirajte svoja interesovanja i budite u toku sa istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Sve informacije temelje se na objavljenim naučnim istraživanjima
